Kozlowski Piotr, Roberts Penelope, Dabora Sandra, Franz David, Bissler John, Northrup Hope, Au Kit Sing, Lazarus Ross, Domanska-Pakiela Dorota, Kotulska Katarzyna, Jozwiak Sergiusz, Kwiatkowski David J
Genetics Laboratory, Division of Translational Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Hum Genet. 2007 May;121(3-4):389-400. doi: 10.1007/s00439-006-0308-9. Epub 2007 Feb 8.
Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by mutations in either of two genes, TSC1 and TSC2. Point mutations and small indels account for most TSC1 and TSC2 mutations. We examined 261 TSC DNA samples (209 small-mutation-negative and 52 unscreened) for large deletion/duplication mutations using multiplex ligation-dependent probe amplification (MLPA) probe sets designed to permit interrogation of all TSC1/2 exons, as well as 15-50 kb of flanking sequence. Large deletion/duplication mutations in TSC1 and TSC2 were identified in 54 patients, of which 50 were in TSC2, and 4 were in TSC1. All but two mutations were deletions. Only 13 deletions were intragenic in TSC2, and one in TSC1, so that 39 (73%) deletions extended beyond the 5', 3' or both ends of TSC1 or TSC2. Mutations were identified in 24% of small-mutation-negative and 8% of unscreened samples. Eight of 54 (15%) mutations were mosaic, affecting 34-62% of cells. All intragenic mutations were confirmed by LR-PCR. Genotype/phenotype analysis showed that all (21 of 21) patients with TSC2 deletions extending 3' into the PKD1 gene had kidney cysts. Breakpoints of intragenic deletions were randomly distributed along the TSC2 sequence, and did not preferentially involve repeat sequence elements. Our own 20-plex probe sets gave more robust performance than the 40-plex probe sets from MRC-Holland. We conclude that large deletions in TSC1 and TSC2 account for about 0.5 and 6% of mutations seen in TSC patients, respectively, and MLPA is a highly sensitive and accurate detection method, including for mosaicism.
结节性硬化症(TSC)是一种常染色体显性疾病,由TSC1和TSC2这两个基因中的任意一个发生突变引起。点突变和小的插入/缺失占大多数TSC1和TSC2突变。我们使用多重连接依赖探针扩增(MLPA)探针组检测了261份TSC DNA样本(209份小突变阴性样本和52份未筛查样本),以寻找大的缺失/重复突变,该探针组设计用于检测所有TSC1/2外显子以及15 - 50 kb的侧翼序列。在54例患者中鉴定出TSC1和TSC2的大缺失/重复突变,其中50例在TSC2,4例在TSC1。除了两个突变外,其余均为缺失。TSC2中只有13个缺失发生在基因内,TSC1中有1个,因此39个(73%)缺失延伸到TSC1或TSC2的5'端、3'端或两端之外。在24%的小突变阴性样本和8%的未筛查样本中鉴定出突变。54个(15%)突变中有8个是嵌合体,影响34% - 62%的细胞。所有基因内突变均通过长片段PCR(LR-PCR)得到证实。基因型/表型分析表明,所有(21例中的21例)TSC2缺失延伸到3'端进入PKD1基因的患者都有肾囊肿。基因内缺失的断点沿TSC2序列随机分布,并不优先涉及重复序列元件。我们自己的20重探针组比MRC - Holland的40重探针组表现更稳定。我们得出结论,TSC1和TSC2中的大缺失分别约占TSC患者所见突变的0.5%和6%,并且MLPA是一种高度灵敏和准确的检测方法,包括对嵌合体的检测。